US Patent Issued to CLARIPI on July 21 for "Optimization method and system for personalized contrast test based on deep learning" (South Korean Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,688,920, issued on July 21, was assigned to CLARIPI INC. (Seoul, South Korea).

"Optimization method and system for personalized contrast test based on deep learning" was invented by Hyun Sook Park (Seoul, South Korea), Chul Kyun Ahn (Seoul, South Korea) and Tae Jin Kim (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are an optimization method and system for a personalized contrast test based on deep learning, in which a contrast medium optimized for each individual patient is injected to implement optimum pharmacokinetic characteristics in a process of acquiring a medical image, the method including: obtaining drug informati...